Open Heart Surgery, Postoperative Pain
Conditions
Brief summary
Effective pain relief after cardiac surgery has assumed importance with the introduction of fast track discharge protocols that requires early weaning from mechanical ventilation. Inadequate pain control reduces the capacity to cough, mobility, increases the frequency of atelectasis, and prolongs recovery. Infiltration of local anesthetics near the surgical wound has shown to improve early postoperative pain in various surgical procedures. Magnesium is the fourth most plentiful cation in our body. It has antinociceptive effects in animal and human models of pain.
Detailed description
Effective pain relief after cardiac surgery has assumed importance with the introduction of fast track discharge protocols that requires early weaning from mechanical ventilation. Inadequate pain control reduces the capacity to cough, mobility, increases the frequency of atelectasis, and prolongs recovery. A major cause of pain after cardiac surgery is the median sternotomy particularly on the first two postoperative days. The most often used analgesics in these patients are parenteral opioids which can lead to undesirable side-effects as sedation, respiratory depression, nausea, and vomiting. Infiltration of local anesthetics near the surgical wound has shown to improve early postoperative pain in various surgical procedures. Magnesium is the fourth most plentiful cation in our body. It has antinociceptive effects in animal and human models of pain. It has been mentioned in a systematic review that it may be worthwhile to further study the role of supplemental magnesium in providing perioperative analgesia, because this is a relatively harmless molecule, is not expensive and also because the biological basis for its potential antinociceptive effect is promising. These effects are primarily based on physiological calcium antagonism, that is voltage-dependent regulation of calcium influx into the cell, and noncompetitive antagonism of N-methyl-D-aspartate (NMDA) receptors. there is a need to evaluate and compare local magnesium with bupivacaine , in comparison to bupivacain ,and other conventional intarvenous analgesics
Interventions
DRUGbupivacain with magnesium sulphate
will receive bupivacain 0.125% and magnesium sulphate 5% infusion in the presternum , for 48 hours
DRUGBupivacaine only
will receive bupivacain 0.125% infusion in the presternum , for 48 hours
DRUGconventional
only conventional post operative analgesics will be used
Sponsors
Assiut University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Intervention model description
pain control in the early postoperative period
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
Criteria: Inclusion Criteria: * 18-60 years old * American Society of Anesthesiologists physical status II and III * Patients scheduled for open heart valve replacement surgery with sternotomy
Exclusion criteria
* Emergency surgery * Clinically significant kidney or liver disease * Patients allergic to local anesthetic * Patients with prolonged CPB time (\>120 min) * Patients required intra-aortic balloon pump
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| postoperative pain | 48 hours postoperative | Vas Scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| extubation time | 48 hours | time to separate patient from mechanical ventilation and extubation |
| Fentanyl consumption | 48 hours | total fenatnyl consumption |
Countries
Egypt
Outcome results
None listed